scPharmaceuticals SCPH 深 滬
已收盤 08-15 16:00:00 美东时间
4.60
-0.350
-7.07%
華盛通- 最 高5.0735
- 今 開4.99
- 成交量 23.02万股
- 最 低 4.59
- 昨 收 4.95
- 總市值 2.43亿
- 52周最高 6.2799
- 市盈率 靜 --
- 換手率 0.44%
- 52周最低 1.94
- 委 比 19.69%
- 總股本 5279.20万
- 歷史最高 18.17
- 量 比 0.39
- 振 幅 9.77%
- 歷史最低 1.94
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多scPharmaceuticals Secures 5 New USPTO Patent Allowances For SCP-111 Furosemide Formulation Ahead Of Supplemental NDA Filing
scPharmaceuticals Inc. (NASDAQ:SCPH) (the "Company"), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, announced today that it has received five Notices of
08-14 20:41
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
scPharmaceuticals Inc.近日宣布，其呋塞米配方SCP-111获得美国专利商标局五项专利授权。这些专利将补充公司现有的四项专利，进一步加强知识产权组合。SCP-111的补充新药申请预计本季度提交。首席执行官John Tucker表示，这些专利对治疗心力衰竭或慢性肾病引起的水肿至关重要，并支持下一代产品开发及市场扩展。
08-14 12:30
scPharmaceuticals Q2 EPS $(0.34) Misses $(0.30) Estimate, Sales $16.041M Beat $15.413M Estimate
scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by 14.09 percent. This is a 22.73 percent increase over losses of $(0.44) per share
08-08 04:04
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
scPharmaceuticals Inc. has scheduled a conference call and webcast on August 7, 2025, at 4:30 p.m. ET, to discuss its second-quarter 2025 financial results and provide a business update. Participants can join via phone or webcast using the provided links and passcode 4965353. The live webcast and replay will also be accessible on the company’s website. scPharmaceuticals, headquartered in Burlington, MA, focuses on cardiorenal care innovations.
07-31 20:01
scPharmaceuticals shares are trading higher after the company reported better-than-expected Q1 sales results.
scPharmaceuticals shares are trading higher after the company reported better-t...
05-15 22:32
scPharmaceuticals Q1 EPS $(0.37) Misses $(0.30) Estimate, Sales $11.75M Beat $11.63M Estimate
scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.30) by 23.33 percent. This is a 2.78 percent decrease over losses of $(0.36) per share
05-15 04:04
快讯 | scPharmaceuticals 2023年第一季度营业费用为2950.9万美元
ScPharmaceuticals Q1 Operating Expenses USD 29.509 Million
05-15 04:01
快讯 | scPharmaceuticals第一季度营业收入美元指数1175.2万， vs. IBES预估美元指数1160万
ScPharmaceuticals Q1 Revenue USD 11.752 Million Vs. IBES Estimate USD 11.6 Mill...
05-15 04:01
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
